MacroGenics Provides Update on Corporate Progress and Third Quarter 2020 Financial Results

NEXT STORY
Harpoon Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
PREV STORY
AnaptysBio Announces Third Quarter 2020 Financial Results and Provides Pipeline Updates
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Myovant Sciences and Pfizer Receive FDA Approval for MYFEMBREE®, the First Once-Daily Treatment for Heavy Menstrual Bleeding Associated With Uterine Fibroids

author_avatar
NASDAQ Market News

Probi and Ipsen sign extensive Primary Care distribution agreement for probiotic LP299V®, Lactobacillus plantarum 299v

Lund (Sweden) and Paris (France), 26 April 2016 Ipsen and Probi today jointly announce ...

author_avatar
NASDAQ Market News

BioSig Expands Its Clinical Footprint In Florida

author_avatar
NASDAQ Market News